Tuberculosis Diagnostics Test Market Share Report, 2025 - 2034

Tuberculosis Diagnostics Test Market - By Test Type, By Modality, By End Use - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/Country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional

2.2.2&nbsp;&nbsp;&nbsp; Test type

2.2.3&nbsp;&nbsp;&nbsp; Modality

2.2.4&nbsp;&nbsp;&nbsp; End use

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising burden of tuberculosis globally

3.2.1.2&nbsp;&nbsp;&nbsp; Advancement in tuberculosis diagnostics techniques

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing awareness and screening programs regarding tuberculosis

3.2.1.4&nbsp;&nbsp;&nbsp; Surge in point-of-care testing (POCT)

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Limited sensitivity and specificity

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory scenario

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technological landscape

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; North America

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Pricing analysis

3.8&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Test Type, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Radiographic method

5.3&nbsp;&nbsp;&nbsp; Diagnostic laboratory methods

5.3.1&nbsp;&nbsp;&nbsp; Microscopy

5.3.2&nbsp;&nbsp;&nbsp; Culture-based techniques

5.3.3&nbsp;&nbsp;&nbsp; Serological tests

5.4&nbsp;&nbsp;&nbsp; Molecular diagnostics

5.4.1&nbsp;&nbsp;&nbsp; Polymerase chain reaction (PCR)

5.4.2&nbsp;&nbsp;&nbsp; Nucleic acid amplification tests (NAAT)

5.4.3&nbsp;&nbsp;&nbsp; GeneXpert MTB/RIF

5.5&nbsp;&nbsp;&nbsp; Detection of latent infection

5.5.1&nbsp;&nbsp;&nbsp; Tuberculin skin test (TST)/ Purified protein derivative (PPD)

5.5.1.1&nbsp;&nbsp;&nbsp; First-generation PPD-based TSTs

5.5.1.2&nbsp;&nbsp;&nbsp; New-generation skin tests with recombinant antigens

5.6&nbsp;&nbsp;&nbsp; Interferon-gamma release assays (IGRAs)

5.6.1.1&nbsp;&nbsp;&nbsp; ELISA-based IGRAs

5.6.1.2&nbsp;&nbsp;&nbsp; ELISPOT-based IGRAs

5.6.1.3&nbsp;&nbsp;&nbsp; Point-of-care IGRAs

5.7&nbsp;&nbsp;&nbsp; Cytokine detection assays

5.8&nbsp;&nbsp;&nbsp; Detection of drug resistance (DST)

5.9&nbsp;&nbsp;&nbsp; Phage assay

5.10&nbsp;&nbsp;&nbsp; Other test types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Modality, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Point of care testing (POCT)

6.3&nbsp;&nbsp;&nbsp; Laboratory-based testing (Non-POCT)

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Pathological laboratories

7.3&nbsp;&nbsp;&nbsp; Other end use

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.2&nbsp;&nbsp;&nbsp; Anhui Zhifei Longcom Biopharmaceutical Co.

9.3&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

9.4&nbsp;&nbsp;&nbsp; bioM&eacute;rieux

9.5&nbsp;&nbsp;&nbsp; Danaher Corporation (Cepheid)

9.6&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche

9.7&nbsp;&nbsp;&nbsp; Generium Pharmaceuticals

9.8&nbsp;&nbsp;&nbsp; Hain Lifescience

9.9&nbsp;&nbsp;&nbsp; Hologic

9.10&nbsp;&nbsp;&nbsp; Japan BCG Laboratory

9.11&nbsp;&nbsp;&nbsp; NIPRO

9.12&nbsp;&nbsp;&nbsp; Oxford Immunotec

9.13&nbsp;&nbsp;&nbsp; Qiagen N.V.

9.14&nbsp;&nbsp;&nbsp; Sanofi

9.15&nbsp;&nbsp;&nbsp; Siemens Healthineers

9.16&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific 
&nbsp;

Tuberculosis Diagnostics Test Market

Get a free sample of this report